Ipilimumab and All-Trans Retinoic Acid Combination Treatment of Advanced Melanoma
Clinical trial NCT02403778 · COMPLETED
Trial details
- NCT number
- NCT02403778
- Sponsor
- University of Colorado, Denver
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-17
- Primary completion
- 2018-08-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.